ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $631,000 | -33.6% | 38,000 | -2.6% | 0.07% | -32.3% |
Q2 2021 | $951,000 | -5.5% | 39,000 | 0.0% | 0.10% | -11.6% |
Q1 2021 | $1,006,000 | -51.8% | 39,000 | 0.0% | 0.11% | -55.9% |
Q4 2020 | $2,085,000 | +29.6% | 39,000 | 0.0% | 0.25% | +4.5% |
Q3 2020 | $1,609,000 | -14.9% | 39,000 | 0.0% | 0.24% | -33.2% |
Q2 2020 | $1,890,000 | +14.7% | 39,000 | 0.0% | 0.36% | -0.8% |
Q1 2020 | $1,648,000 | -1.2% | 39,000 | 0.0% | 0.37% | +15.8% |
Q4 2019 | $1,668,000 | +18.8% | 39,000 | 0.0% | 0.32% | +22.4% |
Q3 2019 | $1,404,000 | +7.2% | 39,000 | -20.4% | 0.26% | -4.8% |
Q2 2019 | $1,310,000 | -14.4% | 49,000 | -14.0% | 0.27% | -18.3% |
Q1 2019 | $1,530,000 | +65.9% | 57,000 | -0.0% | 0.33% | +50.7% |
Q4 2018 | $922,000 | -22.1% | 57,010 | 0.0% | 0.22% | -9.1% |
Q3 2018 | $1,184,000 | +149.8% | 57,010 | +83.8% | 0.24% | +135.9% |
Q2 2018 | $474,000 | -18.8% | 31,010 | +19.3% | 0.10% | +232.3% |
Q1 2018 | $584,000 | -7.6% | 26,000 | +23.8% | 0.03% | -3.1% |
Q4 2017 | $632,000 | +52.7% | 21,000 | +90.9% | 0.03% | +52.4% |
Q3 2017 | $414,000 | – | 11,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |